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Abstract
Nesrine Bouhrira
ESTABLISHING A MECHANISTIC LINK BETWEEN DISTURBED FLOW AND
ANEURYSM FORMATION IN A 3D BIFURCATION MODEL.
2020-2021
Peter A. Galie
Doctor of Philosophy in Biomedical Engineering
The effect of disturbed flow profiles on the endothelium have been studied
extensively in systemic vasculature, but less is known about the response of the bloodbrain barrier (BBB) to these flow regimes. Here we investigate the effect of steady and
pulsatile disturbed flow on the integrity of the BBB using a three-dimensional, perfusable
bifurcation model consisting of a co-culture of endothelial cells with mural and glial cells.
Experimental flow patterns predicted by computational fluid dynamics mimic in vivo flow
regimes, specifically the presence of a recirculation zone immediately downstream of the
bifurcation reveal periodic changes in the instantaneous shear stress along the channel wall.
Dextran permeability assays and immunostaining with markers for tight junctions show
that barrier disruption is significantly greater in areas of disturbed flow compared to fully
developed regions downstream of the bifurcation. RNA sequencing found differences in
gene expression between the disturbed and fully developed regions, and lumican which has
been implicated in ECM organization and collagen fibrillogenisis was shown to be
significantly upregulated in the fully developed region. Furthermore, the downregulation
of the protein is associated with barrier breakdown. Overall, disturbed flow-induced
disruption of the blood-brain barrier suggests that flow-mediated mechanisms may
contribute to vascular pathologies in the central nervous system.
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Chapter I
Introduction
A key determinant in brain pathology and homeostasis is the impact of blood flow
regimes on the integrity of the blood-brain barrier (BBB). Numerous studies have
validated that the integrity of the BBB is sensitive to the wall shear stress applied by
blood flow. While physiological wall shear stress has been shown to maintain barrier
integrity and brain homeostasis, low levels of fluid shear stress have been associated with
higher BBB permeability and disruption of its integrity 1. The breakdown of the BBB has
been associated with several neurological disorders including but not limited to stroke,
Alzheimer’s disease, and traumatic brain injury 2-4. Furthermore, the integrity of BBB is
important at all levels of the vascular tree within the CNS5, including the large arteries in
the subarachnoid space. At these locations, vessels are characterized by temporally and
spatially varying wall shear stress6 due to the pulsatility of blood flow7 and the tortuosity
of the vascular bed at those locations 8, 9. In addition, there is a potential of disturbed flow
regions at these locations due to flow separation from the wall at vascular bifurcations.
These variations have been associated with abnormal flow patterns, non-physiological
wall shear stress profiles and therefore breakdown of the BBB. Several studies have
associated the BBB dysfunction caused by altered blood flow regimes at these locations
with aneurysm initiation, suggesting that altered shear stress may disrupt the BBB at
these locations due to the presence of recirculation eddies caused by disturbed flow.

There is growing evidence suggesting that aneurysm formation is widely
associated with tight junction disruption as well as degradation of the basement
membrane proteins10, 11. Furthermore, there are several signaling mechanisms that could
1

mediate the response to disturbed flow, including mechanosensitive small GTPases, that
upon activation, have been implicated in the regulation of the BBB through the RhoAROCK signaling pathway 12, 13. Moreover, RhoA activation is associated with tight
junction maintenance as well as interactions with extracellular matix (ECM) components,
providing further evidence that the small GTPase may mediate endothelial
mechanotransduction. Therefore, interrogating the impact of time-dependent flow
patterns on the endothelial cells response inside complex vascular geometries mimicking
cerebral vasculatures can elucidate the molecular mechanisms underlying the
mechanotransduction of disturbed flow on the BBB integrity and function.

Previous studies have demonstrated that the phenotype of endothelial cells in
systemic vasculature is markedly different than in the brain 14-16. However, the effect of
altered shear stress on the integrity of the BBB has not been studied as thoroughly1719

.While endothelial cells in the systemic vasculature can withstand hemodynamic stress

and maintain vascular integrity when exposed to laminar flow 20-22, disturbed flows in the
separation zone 9, 23, 24 and reattachment point 25-27 contribute to vasculature dysfunction
and altered gene expression 28. In addition, disturbed flow has been shown to destabilize
cell-cell and cell-ECM contacts adjacent to bifurcations21, 22, 27, 29. Such destabilization in
the brain would lead to barrier breakdown. Yet, the impact of time-dependent disturbed
fluid flow on the integrity of the BBB in a geometry that mimics cerebral bifurcation has
yet to be investigated. Therefore, there is a need for a 3-dimensional (3D) BBB model to
interrogate the response of endothelial cells to the different flow regimes. Previous
studies have used in vitro models to recreate the fluid mechanics of the endothelial
microenvironment25, 26. In contrast to animal models, in vitro models provide a higher
2

level of control over fluid flow regimes exposed to the endothelium. These systems have
applied both steady and pulsatile flow to cerebral endothelial cells in both twodimensional (2D)2, 27, 28 and three-dimensional (3D) geometries30. In contrast, 3D
bifurcation models that create disturbed flow regimes in geometries that are more similar
to in vivo vasculature, are yet to be investigated.

Therefore, the approach described here involves a cerebral bifurcation model
constructed inside a microfluidic device to establish a mechanistic link between disturbed
flow and aneurysm formation in a platform that mimics the brain microenvironment. The
model includes a 3D co-culture of three different cell types. Here, both glial and mural
cells are incorporated into a co-culture model with the endothelium to approximate the
vessel bore that experiences disturbed flow in vivo, since larger arteries exhibit a
prominent mural layer that supports the augmented pressure differences incurred by
higher flow rates. An annulus of smooth muscle cells surrounds the endothelial lumen,
and the annulus itself is surrounded by an astrocyte-seeded hydrogel, to approximate the
arrangement of these cells in vivo 31. Furthermore, the vessels are patterned within a
microfluidic device that is capable of applying different fluid flow levels with a
sufficiently high Reynolds number to separate from the wall of the endothelial lumen,
yielding an experimental setup that can directly interrogate the response of the BBB to
altered shear stress profiles. Here, the desired physiological pulsatile waveform was
successfully generated using a low-cost linear actuator and components fabricated from a
common fused deposition modeling (FDM) 3D-printer. The system divides the task of
ﬂow waveform generation between two components: the peristaltic pump which
generates steady flow and a linear actuator generating oscillations to recreate the systolic
3

and diastolic pressures. The model described here provides a platform to study the effect
of time dependent altered shear stress on the integrity of the BBB in a 3D in vitro setting
that mimics several aspects of the in vivo microenvironment of the brain vasculature.
Throughout the studies, the flow characterization was conducted using both
experimental and computational fluid dynamic models. The cellular response was
quantified using immunofluorescence, immunoblotting, Permeability assays,
Bromodeoxyuridine / 5-bromo-2'-deoxyuridine (Brdu) assays and rheology. In addition,
RNA sequencing along with bioinformatics was used to determine differential gene
expression in the endothelium exposed to steady flow. Finally, gene knockdown was
utilized to modulate the expression of the proteoglycan lumican to probe its impact on the
integrity of the BBB and the activation of the small-GTPases. This dissertation is
organized into five chapters. Chapter 1 is the introduction. Chapter 2 represents the
background information on the BBB and the different flow regimes as well as the current
models used to study the impact of flow on the endothelium in the brain. It finally
introduces the specific aims for the dissertation. Chapter 3 details the experimental
approach utilized, the computational fluid dynamics models and the in vitro experimental
setup. Chapter 4 summarizes the results investigating the impact of both steady and
pulsatile flow on the BBB integrity. It also details the RNA sequencing results to
determine the differentially expressed genes in the endothelium exposed to steady flow.
Finally, it underlines the mechanistic link between the BBB disruption and aneurysm
formation using gene knockdown. Finally, Chapter 5 summarizes all the experimental
approach and results with a discussion of the accomplished work.

4

Chapter II
Background

2.1. The Blood-Brain Barrier (BBB)
2.1.1. Introduction to the BBB. The blood-brain barrier is a complex biological
barrier that separates select blood components from the parenchyma of the brain, which
along with the spinal cord make up the central nervous system (CNS)32-34. It plays a key
role in maintaining brain homeostasis35-37 as well as facilitating the transport of nutrients
and other solutes through the CNS37. The BBB is present in all scales of blood vessels in
the brain38 and is formed by endothelial cells (ECs) lining the brain vasculature, pericytes
and astrocyte end feet35, and a basal membrane that separates ECs from pericytes, and
astrocytes39, 40. The development and maintenance of the BBB are governed by cellular
and non-cellular elements that interact with the ECs. While, astrocytes, pericytes, and the
extracellular matrix (ECM) components provide both structural and functional support to
the BBB, the endothelial cells exhibit a unique phenotype, making the brain capillaries 50
to 100 times tighter than peripheral microvessels as a result of tightly sealed monolayer
of endothelial cells with tight junctions (TJ) and adherens junctions (AJ)41. In addition,
the basal membrane and astrocyte end-feet contribute to BBB function and integrity by
regulating the expression of specific TJ proteins and other BBB transporters.

Brain tight junctions have different biological functions and are composed of
integral membrane proteins including claudins and occludins42 43, which are involved in
intercellular contacts and interactions with cytoplasmic scaffolding proteins such as
zonula occludens-1(ZO-1) proteins (Fig.1) , actin cytoskeleton and associated proteins,
5

such as protein kinases, small GTPases44 and heterotrimeric G-proteins45. They serve to
limit the BBB permeability and increase the barrier’s electrical resistance by limiting
transport through cell-cell junctions.

Figure 1.Schematic of the tight junctions between two endothelial cells

2.1.2. The impact of shear stress on BBB integrity. Several in vitro studies
have shown that formation and maintenance of the BBB in microvascular models
requires exposure to fluid shear stress1, 15. In fact, the wall shear stress applied by the
blood flow has been shown to have a detrimental effect on endothelial cell function,
6

morphology, gene expression and barrier integrity through the regulation of several tight
junction proteins. Several studies have shown that exposure to capillary-like shear stress
levels (6.2 dynes/cm2) increases the RNA levels of a variety of tight and adherens
junction components such as zonula occludens-1 (ZO-1), Claudin 3 and 5, cadherins,
catenin α2 and β1, and actin α21, 46, 47 in addition to reducing barrier permeability and
promoting actin cytoskeleton reorganization 42, 48, 49. However, low levels of fluid shear
stress have been associated with lower expression of tight junction proteins, breakdown
of the barrier and higher permeability.
2.1.3. The impact of the vasculature topology on flow and disease. The BBB
exists at all levels of the vascular tree within the CNS (Fig. 2)5 including the arteries and
arterioles, the dense capillary bed, the venules and veins. Therefore, the integrity of the
barrier is crucial not only in the microvasculature within the brain parenchyma, but also
in the larger pial and cerebral arteries in the subarachnoid space [89]. In these vessels,
the BBB includes an additional layer of smooth muscle cells and is exposed to a time
varying flow and higher Reynolds numbers. There is a potential for disturbed flow,
especially at arterial bifurcations due to the tendency to separate from the wall at these
locations 20, 50. In addition, the vascular topologies exacerbate the blood flow patterns at
these locations6 and expose the endothelium to a time-dependent shear stress field
varying is magnitude during the cardiac cycle, with periodic appearance of flow
separation zones, yielding oscillating wall shear stress profiles6, 9. Therefore, changes in
the blood flow profiles could trigger BBB and TJ disruption, and lead to increased
extravasation of immune cells across the BBB, leading to decreased CNS protection and
potentially to brain inflammation.
7

Figure 2.The vascular neural network 51.

Changes in blood flow have been associated with BBB disruption in several
neuropathological conditions including dementia and Alzheimer’s, epilepsy and ischemic
stroke

2-4

. In addition, evidence that the incidences of aneurysms and endothelial

dysfunction are higher at bifurcations in cerebral arteries

52, 53

suggests that altered shear

stress may disrupt the BBB at these locations.
Several studies investigating the impact of wall shear stress on the vasculature in
the brain demonstrated that flow dynamics play an important role in the initiation, growth,
and rupture of cerebral artery aneurysms54-56. In fact, the wall shear stress applied on the
bifurcation has been shown to play a huge role in aneurysm initiation and rupture. Studies
8

demonstrated that larger bifurcation angles lead to abnormally enhanced hemodynamic
stresses and enlarged zones of direct flow impingement and recirculation eddies54. In
addition, a study conducted by Hassan et.al

55

investigating the response of human

umbilical vein endothelial cells to hemodynamic stresses in an actual patient-specific
cerebral aneurysm model showed that the aneurysmal dome experiences relatively low
WSS compared with the impingement zone at the distal aneurysm neck and downstream
parent vessel. Furthermore, the study showed that high levels of shear stress profiles
impacted endothelial cells morphology and orientation. These results indicate that
abnormal flow profiles lead to the dysfunction of the endothelial cells which in return is
associated with cerebral aneurysms.
2.1.4.

Models of the BBB. To better understand the physiology of brain

vasculature, there is a need to develop experimental models that mimic the properties and
function of the BBB or directly perform experiments in living organisms. Ideal BBB models
mimic the cell types and distribution within the in vivo microenvironment and have high
selective permeability to different substances 35. Several BBB models have been developed
in the past including in vivo, static, and perfusable 2D and 3D models.
2.1.4.1. In vivo models. In vivo BBB models were investigated in the past by
performing experiments in animals. The main advantage of these models is that the
experiment occurs under natural conditions and can generate large amounts of reliable
data 57. In addition, they closely mimic the complexity of human physiology and the brain
microenvironment. In these models, the function of the BBB is studied using several
methods consisting of, intravenous injection and brain perfusion

58

. However, the main

disadvantage of the in vivo studies is the complexity of the in vivo microenvironment that
9

prohibits robust control of the fluid dynamics environment. In addition, animal-to-animal
variability represents an additional limitation that makes in vitro experiments an
alternative for studying the function and response of the BBB to flow.
2.1.4.2.

Current Experimental BBB models. In vitro models for

cerebrovascular studies of the BBB started to emerge in the early 1990s as potential new
research tools complementary to in vivo and human studies. These models are a major
focus in research due to their ability to replicate the vascular properties and the brain
microcapillaries microenvironment. They provide highly controllable environments in
vitro to manipulate cells and tune specific physiological and experimental stimuli
difficult to reproduce in vivo. These models include static culture systems, flow-based
systems, two-dimensional and three-dimensional extracellular matrix-based models. The
primary caveat of these models is the inability to fully recreate the complexity of the in
vivo microenvironment

2.1.4.2.1. Static models. Previous studies have relied on static BBB models
that feature either endothelial cells or multiple cell types cultured on semi-permeable
microporous inserts 59. The mono-culture models represent a simplistic reconstruction of
the BBB and therefore do not capture the complex architecture of the BBB including the
interaction with other cell types, which is crucial for the properties and functions of the
BBB. In co-culture experimental models, brain microvasculature endothelial cells
(BMECs) and other BBB cell types such as astrocytes and pericytes have been cultured
on different sides of a membrane 60. While, the addition of astrocytes has been shown to
facilitate the formation of tight junctions and the overall expression of BBB features,
these models lack a number of necessary features for the development of BBB properties
10

in vitro. They exhibit high permeability due to the absence of physiological stimuli which
significantly limits the ability of the vascular endothelium to develop and maintain the
BBB properties and functions observed in vivo 61, 62 . Lacking the continuous exposure to
wall shear stress, affects the integrity of the barrier and causes major differences in cell
morphology and barrier permeability when compared with in vivo models 63.

2.1.4.2.2. Perfusable BBB models. Recent advances in vascular patterning have
enabled the development of in vitro models that can closely mimic in vivo geometries and
microenvironments 64. These advances can build upon previous BBB models that have
relied on two-dimensional geometries 65, 66 or used three-dimensional models that mimic
small diameter vessels by co-culturing endothelial cells with astrocytes or pericytes 67, 68.
Several models were created using microfluidic chips and a variety of techniques, such as
the gelation of ECM around a removable template rod 69, 70, soft lithography71, and 3D
printing72 . However, microfluidic chip models exhibit unique advantages in the BBB
research due to their ability to mimic the in vivo microenvironment. These devices can be
tuned to meet specific experimental requirements due to their ability to mimic the size of
microvascular structures in vivo and allow for fluid control. Therefore, these models can
be used to interrogate cell morphology, and permeability of the BBB in response to fluid
flow.
While the current 3D BBB models showed their utility to study and characterize
the role of the BBB in the pathogenesis of major neuroinflammatory diseases, they lack a
physiologically relevant diameter to model large arteries in the subarachnoid space that is
necessary to study aneurysm formation. They are also limited due to the inability to support
high Reynolds numbers required to induce flow separation (Re > 100) and sustain high
11

fluid flow levels for a continuous period of time (e.g. 24 h). Moreover, current in vitro
models of cerebral vasculature are inadequate for studying the effects of disturbed fluid
flow due to a lack of three-dimensionality, dependence on synthetic meshes to support the
endothelium and the lack of smooth muscle cells in the co-culture model.
2.1.5.

Endothelial cells used for BBB models. Several endothelial cells types

have been utilized to replicate the BBB characteristics (Table.1). Initially, in vitro models
relied on primary brain microvasculature endothelial cells (BMECs), however these cells
are post-mitotic and difficult to isolate. Therefore, several human and animal cell lines have
been developed to model the BBB to overcome the limitations of using BMECs. Among
these cells, cultured human brain (human brain microvascular endothelial cells, HBMECs)
and non-brain HUVECs vascular cells became available in the early 1980s and exhibit
excellent characteristics for the study of the developmental and pathophysiological
processes of the BBB. Unfortunately, the high level of difficulty associated with isolating
these cells from the brain tissue as well as their rapid senescence, made their use costly and
time consuming. Therefore, immortalized cell lines from diverse origins have been
developed, in the BBB research and include hCMEC/D3, a human adult cerebral
microvascular endothelial cell line73 .These cell lines have many advantages over primary
cultures and other cell types, which include being easy to grow in addition to retaining their
differentiating properties after several passages with a reduced time to reach confluency.
Therefore, they decrease the workload, cost, and labor. But some studies reported that
immortalized cell lines may lose their phenotype after numerous passages, resulting in a
leaky barrier74.

12

Table 1
Summary of previously used endothelial cells to model the BBB
Cells

Advantages

Primary75 76-78

-Close initial resemblance -Post-mitotic
to in vivo conditions
-Difficult to obtain
-Stable over numerous
-Could lose their phenotype
passages
after numerous passages

Immortalized 17, 79, 80

IPSC- derived

81-83

Disadvantages

- Renewable source

-Genetically modified
-Require differentiation and
thorough characterization

-Patient specific 84-88

-Current protocols do not
result
in
a
true
representation of the BBB
phenotype 89
-Can be isolated in large -Not a true representation of
amounts
the BBB phenotype

HUVECS

Fetal derived cells

90-93

-Easy to obtain
-More representative
model

-Generate controversy from
ethics committees

-TJP expression is
characteristic of mature
barrier properties

2.2. Problem Statement And Specific Aims
The following dissertation develops and characterizes an in vitro vascular model of
a cerebral artery that controls both the mechanical and biochemical environment of a coculture of endothelial cells, smooth muscle cells, and astrocytes. The model will interrogate
the overall hypothesis that disturbed flow promotes aneurysm formation by modifying
endothelial gene expression profiles related to extracellular matrix remodeling and the
13

formation of tight junctions. The proposed study is organized into the following specific
aims:
Aim 1: Analyze the effects of disturbed flow on the integrity of the blood-brain barrier
adjacent to arterial bifurcations. Aim 1 assesses the effects of disturbed fluid flow from
both steady and pulsatile flow on blood-brain barrier (BBB) integrity using
immunofluorescence and dextran permeability assays. These studies evaluate the
hypothesis that altered shear stress exerted by disturbed flow disrupts endothelial tight
junctions.
Aim 2: Determine differentially expressed genes in the endothelium exposed to altered
flow regimes using RNA sequencing of vessels exposed to both steady and pulsatile flow.
After interrogating the effect of flow on the BBB, Aim 2 compares gene expression profiles
in regions of the vessel exposed to different flow regimes (fully developed, disturbed,
impingement, and a static control) using next generation sequencing methods (RNA-seq).
The proposed approach tests the hypothesis that disturbed flow alters the expression of
genes in endothelial cells associated with extracellular matrix remodeling and organization
and tight junction formation.
Aim 3: Interrogate the molecular mechanisms underlying the endothelial response to
disturbed flow. Aim 3 focuses on measuring the activation of small GTPases associated
with mechanotransduction and barrier regulation, including RhoA and Rac1, to provide
insight into signaling mechanisms associated with disturbed flow. These studies will also
use the findings of the previous aim regarding differentially expressed genes to investigate
mechanistic effects. Overall, this aim addresses the hypothesis that the expression of

14

extracellular matrix components altered during exposure to disturbed flow mediates
autocrine signaling mechanisms associated with aneurysm formation.

15

Chapter III
Methods and Materials

3.1. Experimental Methods
3.1.1. Vessel fabrication.
3.1.1.1. Microfabrication of microfluidic device. Polydimethylsiloxane (PDMS)
microfluidic devices were manufactured by soft lithography using a previously described
protocol 15. Briefly, SU-8 2025 photoresist (MicroChem) was deposited on a silicon wafer
and exposed to a UV source through a mask with the desired geometry. The inlet was
positioned at an angle of 45 degrees to induce separated flow within the range of Reynolds
numbers appropriate for modeling arterial blood flow (Re = 50-200). PDMS was used to
cast negative and positive molds of the design and to pattern devices on 22mm x 40mm
glass cover slips. The hydrogel reservoir had dimensions of 6.5 x 6.5-mm and a height of
approximately 2-mm. Prior to adding a hydrogel to the device, the reservoir was filled with
5M sulfuric acid, washed with distilled water, and incubated in dilute type I collagen (20
g/mL) to facilitate hydrogel attachment to PDMS

94

. The devices were then sterilized

using short wavelength UV prior to channel seeding.
3.1.1.2. Cell culture. Normal human astrocytes (NHA) (Lonza) were thawed at
passage 5 and cultured for 10 days in astrocyte growth medium (AGM) (Lonza) prior to
seeding in the microfluidic device. Human Coronary Arterial Smooth Muscle Cells
(HCASMC) (Sigma) were also thawed at passage 5 and cultured in smooth muscle growth
medium (Sigma) until confluency, then passaged and cultured in 6 well plates using smooth
muscle cell differentiation medium (Sigma) for 10 days prior to vessel fabrication.
16

Additionally, human cerebral microvascular endothelial cells (HCMEC/d3) received at
passage 19 (gifted from Dr. Robert Nagele’s laboratory) were cultured and expanded on
tissue culture plates coated with 1% gelatin in EGM-2 modified with CD lipid concentrate
and HEPES buffer according to a previously described protocol 17.
3.1.1.3.

In vitro vessel fabrication. Normal human astrocytes (NHA) were

seeded at a density of 1 million cells per mL in a 10 mg/mL collagen, 1.33 mg/mL
hyaluronan (HA) and 1 mg/mL Matrigel hydrogel formulation used in a previous study95.
After injecting the gel directly into the reservoir, an 18-g needle coated with 0.1% Bovine
Serum Album (BSA) (Sigma) was inserted into the device through the 18-g needle guide.
After waiting 20 minutes to allow for gel polymerization, the needle was pulled to create a
cylindrical void, and AGM was added through Port 1 to maintain cell viability. HCASMC
were then seeded into a 10 mg/mL collagen and 1 mg/mL Matrigel composite hydrogel at
a density of 1 million cells per mL. The AGM was aspirated prior to injection of the
hydrogel through Port 3, and a 20-g needle coated in 0.1% BSA in PBS was inserted inside
the void lumen using the 20-g needle guide. The 20-g needle was then removed, leaving a
final cylindrical void and surrounding annulus. HCMEC/d3 were resuspended in EGM-2
at a density of 5 million per mL. 15 μL of the HCMEC/d3-containing solution was injected
into the channel through Port 1 and incubated for 10 minutes, yielding a seeding density of
approximately 150,000 cells per cm2. This process was repeated for an additional 10
minutes after inverting the device to assure uniform lumen coverage throughout the
channel. Silicone grease was used to close the 18-g needle guide and Port 2. Port 2 was
blocked to increase the length of the recirculation zone along the cell-seeded channel by
effectively closing the non-cell seeded branch of the bifurcation. Devices were left in static
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conditions for 2 days submerged in EGM-2 to ensure cell spreading and viability prior to
exposure to flow or static conditions. A total of 29 vessels were fabricated using this
method (three for flow validation, six for proliferation assays and viability assays, five for
immunohistochemistry, and nine for permeability testing).
3.1.1.4. LifeAct transfection. P3 HCASMC cultured in SMC growth medium
(Cell Applications) were transfected with RFP LifeAct lentivirus (Ibidi) at a MOI of 2.5.
Following 48 hours of incubation with the virus RFP positive cells were selected by adding
5 mg/mL Polybrene until only transfected cells remained attached to the culture plate.
Additionally, HCMEC/D3 cells were incubated with lentiviral particles containing copGFP
using a MOI of 1 overnight. The cells were then washed and incubated in EGM-2 and
exposed to 10 mg/mL puromycin until ~90% of adhered cells expressed GFP. Transfected
cells were then cultured and used for experiments as needed.
3.1.2. Barrier integrity assessment.
3.1.2.1. Immunocytochemistry. Four vessels were fabricated using the previously
described method. After two days in static culture following cell-seeding, the vessels were
either left in static conditions or perfused for 24 hours. Upon completion of the experiment,
vessels were fixed in 4% paraformaldehyde (Alfa Aesar) for 30 min at room temperature.
Following fixation, the top layer of the microfluidic device was separated using a razor
blade, and the hydrogel was then removed from the device. Immunolabeling was then
performed after blocking in 3% BSA for 30 minutes at room temperature and incubating
overnight at 4 C in a primary antibody for either zonula occludin-1 (ZO1) (1:250, Cell
Signaling Technology, Product 8193), claudin-5 (1:250, Invitrogen, Product 35-2500),
occludin (1:250 Invitrogen, Product 71-1500), glial fibrillary acidic protein (GFAP)
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(1:100, Santa Cruz, Product sc-166481), or alpha smooth muscle cell actin (1:100,
ThermoFisher, Product 41-9760-80). Gels were then washed three times with PBS for 5
minutes and incubated in the appropriate secondary antibody (1:500, Santa Cruz, assorted),
1:500 Hoechst (Sigma), and FITC-phalloidin (Life Tech, F432) for 1h at 37 C. Confocal
stacks were acquired using a Nikon A-1 confocal scanning microscope.
3.1.2.2. Permeability testing. Nine vessels were used to quantify the
permeability of the vessels following perfusion or static culture. At the completion of the
24-hr experiment, the microfluidic devices were placed on the stage of an inverted
epifluorescent (Nikon Ti-E) and perfused with 4 kDa FITC-dextran (Sigma) at a flow rate
of 10 μL/min using a linear syringe pump over the span of 10 minutes. This flow rate was
chosen to avoid any flow separation and assure fully developed flow throughout the
channel and to maintain consistency with previously described permeability assays
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Images were taken at 30-s intervals and then imported into ImageJ for analysis. The
permeability coefficient was determined using the following equation96:
𝑑𝑖 𝑟

𝑃 = 𝑑𝑡 2𝑙

0

(2)

𝑑𝑖

Where 𝑑𝑡 is the change in florescent intensity of the region of interest outside the lumen, r
is the lumen radius (472 m) and I0 is the maximum intensity in the lumen during the test.
Permeability was measured at three separate locations corresponding to fully developed
flow, near side wall disturbed flow (separated flow), and far side disturbed flow
(impingement flow) (designated as I, II, and III).
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3.1.2.3. Cell proliferation assays. Three additional vessels were constructed for
proliferation assays, which were based in part on a previous study 50. Briefly, vessels were
perfused for 12 hours with EGM-2 using the peristaltic pump and then exposed to 10 M
Bromodeoxyuridine (BrdU) (Alfa Aesar) for the remaining 12 hours. Devices were then
briefly washed in PBS and fixed in 4% v/v paraformaldehyde for 30-min at room
temperature, quickly washed in PBS, and then permeabilized with 0.2% Triton x100 in
PBS for 20 min at room temperature. DNA hydrolysis was performed by removing the
hydrogels from the devices and soaking them in a solution consisting of 4 units per mL
Turbo DNAse (Thermo fisher) and 0.1 mL DNAse Buffer (Thermo fisher) in PBS for 1
hour at 37C. Gels were washed with PBS then incubated overnight at 4 C with 0.8 g/mL
PE-labeled anti-BrdU (Biolegend) and 1% BSA in PBS. Gels were then counter stained
with 1 g per mL Hoechst for 45 minutes at 37C. In ImageJ, thresholding was used to
isolate nuclei prior to using watershedding to isolate individual cells. The ImageJ cell
particle counter was used to count the number of nuclei present at three regions of interest
in both the disturbed (at the stagnation point) and fully developed regions. In the disturbed
region, n = 316-432 Hoechst-positive nuclei were counted. In the fully developed region,
n = 261-340 nuclei.
3.1.2.4. Viability assays. Additional vessels were fabricated for viability
experiments. Viability was assessed using a Live/Dead kit (Biotium) consisting of calcein
AM (2 M) and ethidium homodimer (4 M). Vessels were again incubated in static
conditions for two days prior to application of flow for 24 hours (controls remained in static
conditions for those 24 hours), and then removed from the flow setup, rinsed with PBS,
and incubated for 45 minutes in the staining medium prior to imaging. ImageJ was used to
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calculate the number of live and dead cells in three different regions for each vessel (three
vessels were used for both flow and static conditions).
3.1.2.5. Alignment quantification. Endothelial cell alignment was quantified by
transforming the spatial information from the ZO-1 signal into the frequency domain using
a fast Fourier transform (FFT) calculated by ImageJ as described in a previous publication
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. A Gaussian curve was fit to the frequency data, and the half-width of the curve was

calculated for cells exposed to fully developed and disturbed flow. This process was
repeated for three separate 100 x 100-μm sections from a single immunofluorescence
image.
3.1.2.6. Statistical analysis. Pairwise t-tests were used to compare measurements
of permeability coefficients and positive BrdU staining. Each comparison was made for
sample numbers greater than or equal to 3, and p < 0.05 was considered significant. A test
for normality was performed using the Shapiro-Wilk test, and p<0.05 was considered
statistically different from a normal distribution.
3.1.3. Perfusion.
3.1.3.1. Computational fluid dynamics. A computational fluid dynamics (CFD)
model was used to predict the flow fields present in the 3D vessels patterned within the
microfluidic devices. Prior to the application of flow, brightfield images were acquired of
the vessels and used to generate a SolidWorks model that was imported into a commercial
finite volume code (Star-CCM+) and discretized by a polyhedral mesh. The maximum flow
rate of the peristaltic pump used in our experiments was 4.5 mL/min, so the maximum
Reynolds number within the vessels was calculated to be 191. Thus, the flow was laminar
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in its entirety and there was a sufficient entrance length between Port 1 and the bifurcation
to allow for the flow to become fully developed prior to reaching the bifurcation.
Furthermore, the Reynolds number necessitated inertial terms in the constitutive flow
equation:
⃗ ) = -∇p + μ 𝛻 2 𝑉
⃗
ρ ⃗⃗⃗⃗
(𝑉 ·∇ 𝑉

⃗ is the fluid velocity vector (m/s), p is the fluid
where ρ is the fluid density (kg/𝑚3 ), 𝑉
pressure (Pa), and μ is the dynamic viscosity (Pa-s). Additional prism layers were defined
in the mesh along the wall boundary to ensure that the near wall effects were adequately
resolved. The input flow rate was applied as a velocity boundary condition at Port 1. The
gauge pressure at the 20-g needle guide was set to zero, since this provided the outlet for
the flow. No-slip boundary conditions were applied at the walls and at Ports 2 and 3 and
the 20-g needle guide (locations blocked with silicone grease) to set the velocity to zero
at these boundaries. The simulation was run until the solution converged using a steadystate solver.
3.1.3.2.

Micro-particle image velocimetry flow validation. Micro-particle

image velocimetry (μPIV) was used to validate the CFD model for three independent
channels and to characterize the flow regimes present in these channels. Vessels were
perfused with steady state flow by a syringe pump (Kent Scientific) at the flow rates
determined by the computational model for their individual geometries. These
magnitudes ranged from 4 mL/min to 4.5 mL/min. Polyethylene microspheres labeled
with Nile Red (Peak excitation: 640nm; mean diameter 1.95 μm; Spherotech Inc.) were
suspended 1:500 in PBS containing 0.1% Triton X-100 to prevent bead aggregation and
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illuminated and visualized with a dual pulse Nd:YAG laser (125mJ/pulse, 15 Hz, 532
nm; Dantec Dynamics). The pulse width of the lasers was set to 100 ns and the
illumination set at a frequency of 0.1 Hz for two seconds (20 individual velocity
measurements). Particles were visualized with 10x objective on a Nikon Ti-E inverted
microscope, where the focal plane was set to the channel’s midpoint. Images were
captured using a double-frame CCD camera (FlowSense EO, Dantec Dynamics).
Velocity contours were calculated in Dynamic Studio (Dantec Dynamics) using an
adaptive PIV algorithm. Velocity contour plots were generated in MATLAB by taking
the mean of the 20 velocity measurements. In order to calculate the shear stress at points
along the vessel wall, a second order polynomial was fit to the velocity in the boundary
layer, and the slope of that function at the wall was calculated.

3.1.3.3.

Design of the pulsatile flow system. The peristaltic pump system

was controlled using an Arduino-based system
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. A peristaltic motor (Welco) was

controlled by an Arduino Uno (Arduino) and a motor board (Ada Fruit). The flow rate
magnitude was controlled by using the Arduino to regulate DC voltage powering the motor.
A Sensiron flow sensor was used in-line of the perfusion system to monitor the steady flow
rate and pulsations. To mimic the arterial pulsation, the pulsatile flow system was designed
by superposition of oscillations with the constant mean ﬂow driven by the peristaltic pump.
The system included a damper placed in series with the channel, to eliminate the
oscillations coming from the peristaltic pump, and a Limnot® linear motor, which was
programmed to generate the ﬂow waveform via displacing a 5 mL syringe connected to the
actuator system using the LinMot software (open source)99. 120mm 12v fans (Corsair)
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were mounted to the linear motor to regulate the temperature and prevent the system from
overheating.
3.1.3.4.

3D printing and system assembly. The linear actuator along with

the 5mL syringe were placed on a 3D printed assembly system to facilitate the movement
of the actuator and the syringe while fixing the other components in place. The 3D printed
parts were designed using Solidworks then, imported into ultimaker 2+ platform for 3D
printing. A total of 5 components (supplemental figure 1) were printed in less than 20
hours. The syringe movement was then facilitated by the placement of linear bearings and
rods (McMaster) inside components 1,2 and 3. The system was then mounted to a platform.
3.1.3.5.

Flow control. To apply flow to vessels over a 24-hour timespan, a

custom peristaltic pump system was built using an Arduino-based control system. A
peristaltic motor (Welco) was controlled by an Arduino Uno (Arduino) and a motor board
(Ada Fruit). A Sensiron flow sensor was used in-line of the perfusion system to monitor
the applied steady flow rate. System schematics are shown in Supplemental Figure 2. The
code to control the pump was written and compiled in Arduino IDE (Arduino) using open
source libraries available within the IDE. To minimize pulsations in the system, a dampener
was placed in series with the vessel.
3.1.3.6.

Dynamic mechanical testing. Hydrogels with and without

astrocytes were polymerized within the central reservoir of the microfluidic devices, and
then removed after two days in static culture and transferred to a compression platen for
axial dynamic mechanical testing (EZ-SX, Shiamadzu). Due to the fixed geometry of the
microfluidic reservoir, all hydrogels had dimensions of 1-cm width, 1-cm length, and 1.6mm height. The hydrogels were compressed at a frequency of 0.5 Hz between 0 and 15%
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strain in an unconfined configuration. The complex modulus was calculated by the ratio of
the maximum stress and maximum strain. The phase shift between the stress and strain
waveforms was used to determine the loss angle, and consequently the storage and loss
modulus of the hydrogels. Three samples were tested for both cellular and acellular
conditions (six total samples).
3.1.4. RNA sequencing.
3.1.4.1.

mRNA extraction. To measure gene expression profiles in the

different flow regimes, channels were removed from the microfluidic devices after 24
hours of flow and sectioned into disturbed, impinged, and fully developed regions based
on their geometry using a razor. For each region, the endothelial cell layer was separated
from the rest of the gel prior to RNA extraction. Two channels for each condition were
required to produce a sufficient quantity and quality (RIN > 6.0) of mRNA. The mRNA
was extracted using the PicoPure isolation kit. Twenty-one total channels were required
for these experiments (three channels in duplicate for both steady and pulsatile flow
besides three channels for static condition as a control). For quantitative and qualitative
analysis, the Nanodrop spectrophotometer was used to measure the RNA concentration
and quality. Quality was indicated by measuring the absorbance ratios (260/280). Ratios
around 1.8 were classified as pure and therefore acceptable for gene sequencing.
3.1.4.2.

Gene sequencing and Bioinformatics. The mRNA was shipped to

an external company (GeneWiz) for next generation Sanger sequencing. To analyze the
sequencing data, a group of open source bioinformatics software programs (FastQC,
Trimmomatic, Htseq, STAR) along with a high-performance computing cluster (16 cores,
60GB) was used to read the sequences and perform a quality control check, trim the bad
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reads, align reads to the genome, and count the reads per gene. The disturbed, impinged,
and static conditions were compared to the fully developed region as a reference.
3.1.5. Polymerase chain reaction.
3.1.5.1.

Astrocyte message level quantification. After perfusion, hydrogels

were removed from the microfluidic device and cut into regions representative of disturbed,
impingement, and fully developed regions. mRNA from the astrocytes was isolated using
PicoPure RNA Isolation kits (Thermo Scientific) and reverse transcribed to cDNA using
qScript (Quantabio). Quantitative PCR was then performed with SYBR Green reagents,
with the primers given in Table 1 used to amplify targets. Tests were conducted in triplicate
for each region.

Table 2
Primer sequences for astrocyte qRT-PCR
Primer

Forward Sequence

Reverse Sequence

NONO GTGTAGCGTCGCCGTTACTC

CCTTCATTTTGGCTGCTGGC

VEGF

GACATTGCTGTGCTTTGGGG

HIF1a

TGGCAACCTTGGATTGGATGGA CCGTCCCTCAACCTCTCAGT

GFAP

CAAAAGCACCAAAGACGGGG
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AAGGGGAGCAGGAAGAGGAT

GAGGCTCACTCCCTGTCAAG

Message levels were double normalized to Non-POU domain-containing octamerbinding protein (NONO) from a collagen-only sample. Relative expression was quantified
as 2-ΔΔCT where CT is cycles to threshold. Data are presented as the averaged fold change
of collagen/HA gels compared to collagen only gels.
3.1.5.2. Endothelial cells message level quantification. After perfusion, hydrogels
were removed from the microfluidic device and cut into regions representative of disturbed,
impingement, and fully developed regions. mRNA from the endothelial cells was isolated
using PicoPure RNA Isolation kits (Thermo Scientific) and reverse transcribed to cDNA
using qScript (Quantabio). Quantitative PCR was then performed with SYBR Green
reagents, with the primers given in Table 1 used to amplify targets. Tests were conducted
in triplicate for each region.
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Table 3
Primer sequences for endothelial qRT-PCR
Primer

Forward Sequence

Reverse Sequence

NONO GTGTAGCGTCGCCGTTACTC
Lumican TCATCCCTGGTTGAGCTGGAT

CCTTCATTTTGGCTGCTGGC
AGGATAATGGCCCCAGGATCT

MMP1

AAAATTACACGCCAGATTTGCC

GGTGTGACATTACTCCAGAGTTG

MMP3

AGGACAAAGCAGGATCACAGTTG CCTGGTACCCACGGAACCT

MMP10 TTACATTGCTAGGCGAGATAGG

CAGTCACAGAACATGCAGGAA

MMP12 GATGCTGTCACTACCGTGGGAA

CAATGCCAGATGGCAAGGTTGG

Message levels were double normalized to Non-POU domain-containing octamerbinding protein (NONO) from a collagen-only sample. Relative expression was quantified
as 2-ΔΔCT where CT is cycles to threshold. Data are presented as the averaged fold change
of collagen/HA gels compared to collagen only gels.
3.1.5.3.

Statistical analysis. The open source statistics package, R, was used

to perform all statistical analysis. Edge R package was used to determine the differentially
expressed genes. To get a sense on how correlated the samples are, a PCA (Principal
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component analysis) was performed on the data to reduce the number of columns using the
Variance, covariance, covariance matrix, eigenvalues and eigenvectors.
3.1.6. Lumican knockdown.
3.1.6.1.

Lumican knockdown. Lumican knockdown was performed to alter

its expression prior to flow experiments, using siRNA transfection with both a target
sequence and scrambled sequence for a control. Cells were transfected using the
appropriate protocol from Santa Cruz biotechnology. Briefly,cells were plated in a 6-well
plate at 200k per well until they reached 60-80% confluency. A mixture of transfection
reagent and transfection media was added to the transfection solution, and then to the
cells. The transfected cells were incubated at 37 C for 6 hours, then the transfection
solution was removed and replaced by EGM-2 for 24 hours prior to seeding.
3.1.6.2.

Western blot for transfection efficiency. Transfection efficiency

was verified by western blotting: cells were lysed in sample buffer containing DTT and
LDS, boiled, and loaded onto a gel and separated with electrophoresis. Proteins were
transferred to a 0.45-µm PVDF membrane. Blots were quantified by measuring band
intensity using ImageJ and normalizing relative expression to scrambled conditions.
Membranes were incubated with anti-lumican (1:100, Santa Cruz, sc-166871) primary
antibodies and visualized with HRP-conjugated secondary antibodies (1:4000, CST
L27L9)
3.1.6.3. Permeability testing. Following knockdown validation, twelve channels (n
= 6 for knockdown, n = 6 for control) were exposed to steady and pulsatile flow for 24
hours, and permeability experiments were conducted to evaluate the impact of lumican
knockdown on barrier integrity by perfusing channels with 4KDa dextran.
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3.1.6.4. Immunofluorescence. Four vessels were used in this section. Two vessels
were perfused for 24 hours, and two others were transfected then perfused for the same
period of time. Upon completion of the experiment, vessels were fixed in 4%
paraformaldehyde (Alfa Aesar) for 30 min at room temperature. Following fixation, the
top layer of the microfluidic device was separated using a razor blade, and the hydrogel
was then removed from the device. Immunofluorescence was then performed after
blocking in 3% BSA for 30 minutes at room temperature and incubating overnight at 4 C
in a primary antibody for zonula occludin-1 (ZO1) (1:250, Cell Signaling Technology,
Product 8193).Gels were then washed three times with PBS for 5 minutes and incubated
in the appropriate secondary antibody (1:500, Santa Cruz, assorted), 1:500 Hoechst
(Sigma), FITC-phalloidin (Life Tech, F432) and Lumican conjugated to Alexa 488
(Santa Cruz sc-166871 AF488) for 1h at 37 C. Confocal stacks were acquired using a
Nikon A-1 confocal scanning microscope.
3.1.7. Monolayer experiments using flat gels.
3.1.7.1. Cell seeding and flow experiments. For the monolayer experiments, the
same hydrogel formulation used in the annulus was polymerized on the treated PDMS
coated plates under a sterile 40-mm glass coverslip to create a uniform circular hydrogel
to replicate the fully developed flow and 12-mm glass coverslip for disturbed flow.
Following removal of the cover slip, HCMEC/d3 were seeded on the gel at a density of
4k/cm2 and allowed to adhere for 30 minutes prior to addition of EGM-2. Monolayers
were incubated for 2 days in static culture to ensure confluency, then exposed to fluid
shear stress. Fully developed fluid shear stress was applied using a 40-mm 1- degree cone
plate on a rheometer (Waters) for 24-hrs on a Peltier plate set to 37oC. Shear stress
30

gradient was applied using a 40-mm flat plate to mimic the shear stress profiles
experienced by disturbed flow. The media was supplemented with HEPES buffer to a
final concentration of 10 mM to maintain pH and sterile Millipore was added to the plate
during exposure of flow to counteract evaporative loss.
3.1.7.2. Lumican expression quantification. Lumican expression was performed
using cell lysates extracted from cell monolayers cultured on the collagen hydrogels
exposed to 24hrs of fully developed and disturbed fluid shear stress applied by a cone and
plate rheometer. The gels for each condition were removed from the rheometer and
washed immediately in ice cold PBS. The gels were then submerged in ice cold lysis
buffer (CST) and sonicated. Gels were then spun down at 14,000 g for 5 minutes at 4oC.
Supernatants were removed and snap frozen reserving a small aliquot for protein
quantification. Samples were equilibrated at 0.5 mg/mL protein concentration using ice
cold lysis buffer after thawing in a room temperature water bath. Samples were then
loaded on a tris-acetate gel and separated using electrophoresis in tris-acetate buffer.
Protein was transferred to a 0.45-µm PVDF membrane. The membrane was incubated
overnight with Lumican antibody (1:100) (Santa Cruz, sc-166871) and visualized with
HRP-conjugated secondary antibody (1:4000) (CST, L27L9).
3.1.8. Small GTPase activity.
3.1.8.1. ELISA-based quantification of small GTPase activity. To determine the
effect of lumican knockdown on small GTPase activity, commercial ELISA kits were
purchased from Cytoskeleton (G-LISA) to quantify RhoA activation (Cytoskeleton). For
the knockdown and scrambled control, cell lysates were prepared using Cytoskeleton’s
protocols. Following exposure to flow, vessels were washed with ice cold 1x PBS for 30
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seconds. In order to isolate sufficient protein quantity, endothelial cells lysates were
prepared from two total vessels for each condition, therefore 100 µL of ice-cold cell lysis
buffer with 1x protease inhibitor was injected into each vessel and collected in a
microcentrifuge tube. The cell lysate solution was spun at 10,000 g for 1 minute at 4oC to
pellet cell debris. The supernatant was collected and snap frozen in liquid nitrogen,
reserving a small amount for protein quantification using Precision Red (Cytoskeleton).
Prior to measuring GTPase activity, samples were thawed in a room temperature water
bath and equilibrated to 0.8 mg/mL for RhoA samples. In order to complete these
experiments in triplicate, a total of 12 vessels were fabricated for these studies (Six
vessels for each condition).
3.1.9. Lumican mechanics.
3.1.9.1. Fibrillogenesis. Turbidity tests were conducted to assess the
microstructure of collagen fibril formation and organization. Collagen fibril formation
was measured as previously described100-102 at 340 nm in a UV sensitive 96-well plate in
a plate reader. Each assay consisted of 100 μl of collagen at 20 mg/ml and variable
concentrations of recombinant human lumican (VWR)
(0.15mg/mL,0.5mg/mL,1.5mg/mL) using distilled water as diluent. All solutions were
maintained at 4 °C. Collagen was added to the proteoglycan, mixed by pipetting and
reading initiated immediately. Turbidity was measured every 2 min for 60 min. Readings
were blanked against the diluent buffer and data were compared to collagen without
recombinant lumican as a control. Experimental turbidity curves were analyzed in terms
of the maximum rate of turbidity change observed.
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3.1.9.2. Rheology. To determine the impact of lumican on the mechanical
properties of the ECM. Recombinant lumican was prepared and added to the collagen gel
at different concentrations 102. Lumican-collagen composite gels was polymerized on a
strain-controlled rheometer and the viscoelastic mechanical properties of the gels was
assessed as a function of lumican concentrations. Both storage and loss moduli and loss
angle were measured for a range of strain magnitude of 0.1% and frequency of 50 Hz,
respectively. Data were compared to collagen without recombinant lumican as a control.
Each experiment was conducted in triplicates
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Chapter IV
Results
4.1. Impact of Steady Disturbed Flow on Barrier Integrity
4.1.1. Fabrication and characterization of a 3D in vitro model of a cerebral
bifurcation. A microfluidic device was designed to apply bifurcation flow profiles to a
3D model of a cerebral artery, consisting of an endothelial intima and a smooth-muscle
containing media layer surrounded by astrocytes. The device schematic in Figure 3A
indicates the location of a 944-μm diameter endothelialized lumen surrounded by a
smooth muscle cell-containing annulus with an outer diameter of 1.2 mm in a hydrogel
seeded with astrocytes. To induce flow separation, defined as a disruption of a fully
developed boundary layer, the flow inlet and cell-seeded vessel were offset by 45
degrees. Figure 3B shows a cross-section at the midpoint of the channel after 3 days in
culture, indicating a confluent monolayer of GFP-positive endothelial cells (hCMEC/D3),
an annulus of LifeAct-RFP expressing smooth muscle cells (hCMASMC), and an outer
hydrogel of glial fibrillary acidic protein (GFAP)-positive astrocytes (NHA). Figure 3C
provides a 3D reconstruction of the co-culture vessel, further verifying the stable
stratification of the three cell types within the model.
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Figure 3. Fabrication of a 3D cerebral bifurcation model. A) Schematic of the
microfluidic device showing the location of the ports and the needle guides used to create
the layered cell-seeded vessel, B) Cross-section of the vessel at its midpoint with GFPlabelled endothelial cells (green), LifeAct-RFP smooth muscle cells (red), and GFAPpositive astrocytes (magenta). scale = 100 m. The arrow indicates the flow direction. C)
3D reconstruction of vessel scale = 100 m. D) Storage moduli (i), loss moduli (ii), and
phase angle (iii) of hydrogels seeded with and without astrocytes. (n = 3) E) Astrocytes
labeled with DAPI (blue), phalloidin (red), and anti-GFAP (green). F) GFP-labeled
endothelial cells (green) exhibiting ZO-1 at cell-cell junctions (red). G) α-SMA-positive
smooth muscle cells. Scale bars are 25m in E, F, and G.
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Preliminary flow tests in the microfluidic device revealed that astrocytes were
needed within the hydrogel to prevent collapse of channels exposed to high flow rates.
Given that previous studies have demonstrated that embedding astrocytes within
collagen/hyaluronan composite matrices affects their viscoelastic properties103, we
conducted dynamic mechanical testing of hydrogels with and without astrocytes. The
compression testing indicated that hydrogels seeded with astrocytes featured an increased
storage modulus (Fig. 3D,i), decreased loss modulus (Fig. 3D,ii), and reduced phase angle
(Fig. 3D,iii) compared to acellular controls. This finding is consistent with our previous
result that astrocytes alter the mechanical properties of a constrained collagen/hyaluronan
hydrogel by exertion of cell-generated forces on the matrix103. Hence, astrocytes were
required in the model not only to mimic the glial cells surrounding cerebral vasculature in
vivo, but also to sustain forces exerted by high Reynolds number flow.
Immunofluorescence analysis using cell type-specific markers verified that the
three cell types retained their phenotype after several days in the co-culture. Figure 3E
shows the astrocytes within the outer hydrogel: the cells attached to the extracellular matrix
and exhibited positive staining for GFAP, a marker of astrocyte activation. Figure 3F
provides an image of the confluent endothelial monolayer lining the vessel lumen. After
the application of flow, the endothelial cells exhibited localization of zonula occuldin-1
(ZO-1) to the cell-cell junctions, indicative of tight junction formation. Finally, the smooth
muscle cells within the annulus maintained their phenotype, as evidenced by positive
staining for α-smooth muscle cell actin (α-SMA) (Fig. 3G).
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4.1.2. Characterize the steady flow patterns inside the cerebral bifurcation
using uPIV and CFD. Disturbed flow was defined by the disruption of a parabolic
velocity profile characteristic of fully developed flow and the presence of a recirculation
eddy caused by the separated flow. In the computational simulations, the eddy occurred
on the near side of the cell-seeded vessel directly downstream of the bifurcation. The
location along the wall where the wall shear stress was equal to zero was designated as
the stagnation point of the flow. The computational model determined the flow rate that
assured the location of the stagnation point was consistent for all geometries, in order to
create a reproducible flow field.
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Figure 4. Flow characterization of the bifurcation. A,i) Velocity contour plot generated
with the CFD software using a flow rate of 4 mL/min. A,ii) A radial velocity plot in the
disturbed region (purple dotted line) and A,iii) fully developed region (purple solid line).
B) Velocity contour plot within the boxed region of panel A. C) Velocity contour plot
measured with microparticle image velocimetry and processed with a MATLAB code. D)
Velocity profile along the channel radius at x= 0.18 mm E) x= 0.33mm, F) x= 0.55mm
and, G) x= 1 mm. Error bars indicate the standard deviation between 20 frames.

A 3D computational fluid dynamics (CFD) model was constructed to characterize
the flow within the microfluidic device and to determine the flow rate required to cause
flow separation along the cell-seeded vessel. A brightfield image of the channel geometry
was imported into SolidWorks, discretized, and meshed using a commercial CFD code
(Star CCM+). The CFD model predicted flow separation at the near wall of the cell-seeded
vessel for an input flow rate of 4 mL/min (Fig. 4A,i). At this location, the velocity profile
was no longer parabolic and a recirculation eddy was present. The flow reattached to the
wall 2.2-mm downstream of the vessel inlet, as evidenced by the onset of constant wall
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shear stress and a fully developed velocity profile. Radial velocity plots in the disturbed
(Fig. 4A,ii) and fully developed (Fig. 4A,iii) regions indicated the flow separation caused
by the bifurcation. A velocity contour at the bifurcation (Fig. 4B) further exhibited the
asymmetric flow profile and separation from the near wall of the cell-seeded vessel.
In order to validate the computational model, microparticle image velocimetry
(PIV) was used to quantify the velocity profile within the vessel. Flow was applied at the
4-mL/min rate used in the computational model, and the velocity contour was measured
within the cell-seeded vessel. As Figure 4C indicates, PIV demonstrated a similar region
of separated flow at the inlet of the cell-seeded vessel as the computational model (Fig.
4B). At four distances from the inlet of the cell-seeded vessel (x = 0.28 mm, 0.33 mm, 0.55
mm, and 1 mm), the velocity profiles predicted by the computational model were compared
to the measurements from the PIV measurements (Fig. 4D-G). The plots indicate close
agreement between the predicted velocity distributions and those measured by PIV. For
most data points, the computational value falls within one standard deviation of the
experimental measurement, with the exception of the contour at x = 1-mm (Fig. 4G) where
the computational model overestimates the velocity measured experimentally at radial
distances varying from 0.2 to 0.5-mm. A possible cause for this discrepancy is small
variations in channel geometry caused by perfusion. To interrogate the effect of perfusion
on channel geometry, the deformation of the channel walls was measured during the
application of 4.5 mL/min flow and found to increase by 0.5 +/- 0.01% on average along
the channel length (measured in three locations for three separate channels). The deformed
geometries were then input into the computational model to determine its effect on
predicted velocity distribution at x = 1-mm. As Supplemental Figure 3 indicates, changes
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to the wall geometry caused by perfusion do not substantially alter the wall shear stress
along the channel, suggesting that another factor is likely responsible for the discrepancy
in Figure 4G. Nonetheless, the maximum velocity and asymmetry of the distributions were
consistent between calculated and experimental data, validating the accuracy of the
computational model.

Figure 5.Generalized model to account for geometric variation: A) Schematic of the
bifurcation detailing the parameters used to quantify differences in vessel geometry. B) A
brightfield image indicating the location of these parameters in a sample vessel. C) Wall
shear stress profiles generated with CFD for three different geometries and flow rates
varying from 4-4.5mL/min. D-F) comparison plots between the experimental and
measured wall shear stress (WSS) profiles along a 1.2-mm length of the near wall of the
disturbed region for geometries 1,2 and 3. Error bars indicate the standard deviation of 20
measurements.

40

Having demonstrated the efficacy of the computational model to predict velocity
distributions within the device, additional work was conducted to assure that reproducible
flow profiles could be applied to multiple channels despite small differences in channel
geometry caused by the placement of needles within the hydrogel. Therefore, in order to
create a repeatable system for cell studies, an approach was developed to normalize the
flow fields for varying geometries. Specifically, the computational model was used to
determine the flow rate required to fix the location of the flow stagnation point (where wall
shear stress was equal to zero on the near side wall) at the same distance from the inlet
regardless of the channel geometry. Four parameters were used to describe the channel
geometry prior to application of flow, depicted in Figures 5A and 5B. These parameters
provided insight into the position of the hydrogel within the microfluidic device in order
to account for slight differences in the placement and orientation of the cell-seeded vessels.
Parameters A and B indicated the extent to which the channel was centered within the
device, and Parameters C and D described the lateral placement of the hydrogel. Table 2
summarizes the values of these four parameters for three different channel geometries
(Geometry 1, Geometry 2, and Geometry 3).
For the three geometries, the average and standard deviation of the stagnation point
was predicted to occur at 0.543 mm +/- 0.029 mm and the length of the disturbed region
was 2.17 mm +/- 0.44 mm for flow rates varying from 4 to 4.5 mL/min. The predicted
shear profiles along the near-side wall of the vessel are shown in Figure 5C. Due to the
changes in flow rate, the average shear stress among the three geometries in the fully
developed region downstream of the bifurcation was 0.835 Pa +/- 0.056 Pa, which is
consistent with physiological levels for the middle cerebral artery
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. PIV was used to

validate the shear stress profiles for the three geometries along a 1.2-mm-length of the
channel adjacent to the bifurcation on the near wall (Figs. 5D-F). The plots show close
agreement between the predicted shear stress distributions and those measured by PIV.
Importantly, the distributions all indicate substantial recirculation zones and a similar
stagnation point for all three geometries. These results verify that the stagnation point of
the flow can be fixed regardless of small changes to vessel geometry, allowing for a
reproducible flow environment for studying the endothelial response in multiple samples.
4.1.3. Evaluate the impact of flow regimes on the BBB integrity.
4.1.2.1. Effects of disturbed fluid flow on endothelial tight junctions and
morphology. Having demonstrated that disturbed flow could reproducibly be applied to
the vessels despite inconsistencies in channel geometry, experiments were conducted to
assess the effect of disturbed flow on the integrity of tight junctions within the endothelial
monolayer. In vitro vessels were either exposed to flow for 24-h with flow rates that caused
flow separation at the location of the bifurcation or cultured in static conditions as an
additional control. Imaging of the monolayer exposed to static conditions revealed that ZO1 was not fully localized to cell-cell junctions (Fig. 6A,i-ii). In contrast, endothelial cells
exposed to fully developed flow exhibited ZO-1 localization to the cell-cell junctions (Fig.
6B,i-ii). In the disturbed region, images of the endothelium at the stagnation point indicated
a disorganized monolayer with substantially less ZO-1 staining at the junctions (Fig. 6C,iii). FFT analysis suggested that the cells in the fully developed region were significantly
more aligned in the direction of flow than cells in the disturbed region (Fig. 6D-E). To
provide further evidence of tight junction formation and disruption in these different
regions, vessels were also treated with antibodies for claudin-5 and occludin, two
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additional markers for the tight junctions that are characteristic of the BBB. These images
are provided in Supplementary Figure 4.

Figure 6. Effects of disturbed flow on endothelial cells tight junctions: A-C) Composite
images of ZO-1 (red), DAPI (blue), and phalloidin (green) (i) and with ZO-1 isolated (ii)
of the endothelial cells along the near side wall in static conditions (A) and in
perfusedchannels at the fully developed (B) and stagnation point of the disturbed region
(C). Scale for A-C: 25 m D) Gaussian distribution of the actin fibers fitted to results of
FFT analysis. E) Width at half height of the distributions for disturbed and fully
developed regions. * p < 0.05.
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4.1.2.2 Effects of disturbed fluid flow on endothelial cell proliferation and
viability. As shown in Figure 7, the endothelium in the disturbed region appeared to have
a higher cell density than the region in the fully developed region downstream of the
bifurcation. To determine whether disturbed flow augmented proliferation in the
disturbed region, a BrdU assay was conducted to compare the number of cells in S-phase
between the disturbed and fully developed regions. Based on channel geometries, flow
rates were chosen to match the wall shear stress distributions used in the
immunofluorescence and permeability assays and applied for 24-h. After 12-h, BrdU was
added into the perfusing medium. Imaging of the fully developed region showed few
BrdU-positive nuclei (Fig. 7A) In contrast, the disturbed region (Fig. 7A) exhibited an
increased number of BrdU-positive nuclei (and higher number of nuclei overall) at the
location of the stagnation point of the near wall (Fig. 7B). Quantification of the disturbed
and fully developed regions indicated a significant increase in the number of BrdUpositive cells. In the disturbed region: 65% of cells were in S-phase compared to only 3%
in the fully developed region (Fig. 7C). This result is consistent with previous studies that
found increased endothelial proliferation is associated with barrier breakdown 105.
To verify that endothelial cell viability was not affected by the different flow
regimes, a Live/Dead assay was conducted for static,disturbed, and fully developed
conditions. Across all conditions, the viability exceeded 92% regardless of the shear stress
exerted on the endothelium. Furthermore, there were no significant differences in the
number of viable cells between static (Fig. 7D,i), fully developed (Fig. 7D,ii), and disturbed
(Fig. 7D,iii) conditions. Figure 7E provides a summary of the quantified data, indicating
no significant difference in viability between the different flow regimes. These results
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indicate that although cells in the disturbed region proliferated at a higher rate, they
remained viable during the flow experiments.

Figure 7. Effects of disturbed flow on endothelial cell proliferation and viability: A-B)
DAPI (i) and BrdU (ii) staining of the endothelial lumen for fully developed (A) and
disturbed (at the stagnation point of the near wall) (B) regions. Scale bars = 25 m. C)
Percent of BrdU-positive nuclei (n=3). *indicates p < 0.05. D) Live (green) / Dead (red)
assay for cells exposed to static (i), fully developed (ii), and disturbed (iii) flow. Scale bars
= 100 m. E) Quantification of Live/Dead assay for three different vessels for each
condition (n = 3). N.S indicates no significant difference.
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4.1.2.2. Quantification of vessel permeability and endothelial-mural/endothelialglial interaction. Permeability testing provided a quantitative means to assess the integrity
of the barrier in response to varying flow regimes. Devices were perfused with dextran to
quantify barrier integrity after 24-h of perfusion. The permeability coefficient was
measured at the fully developed region downstream of the bifurcation (I) and at the near
wall (where flow separates) (II) and far wall (III) adjacent to the bifurcation in the area of
disturbed flow. Figure 8A provides an image of a vessel being perfused with dextran to
assess barrier permeability and denotes the three regions where the permeability was
measured. Figure 8B indicates that the permeability is significantly higher in not only the
near wall of the disturbed region (II) compared to the fully developed region (I), but also
at the far wall of the disturbed region (III). At this location, the vessel wall experiences
impingement flow: the shear stress was elevated compared to other regions of the vessel
(1.4 Pa +/- 0.22 Pa) and the shear varied along the axial direction of the vessel. This result
supports previous studies linking impingement flow 106 and high shear stress 106 to vascular
dysfunction in the brain. In order to verify that the increased dextran transport adjacent to
the bifurcation was not due to leakage from the side of the hydrogel, the gradient of
fluorescence intensity was graphed in both the axial and radial direction for the disturbed
region. Measurements indicate that there is no gradient of fluorescence along the axial
direction, indicating that the transport of dextran into the hydrogel originates from the
disturbed portion of the cell-seeded vessel. Overall, these permeability tests verify the
results of the tight junction staining that suggest disturbed flow disrupts barrier function.
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Figure 8. Effect of disturbed flow on vessel permeability and smooth muscle cell and
astrocyte interaction. A) An image of dextran perfusion indicating the location of
permeability measurements: I) Fully developed, II) Disturbed on the near side wall
(separated flow),III) Disturbed on the far side wall (impingement flow). B)
Quantification of the permeability constant at these three regions and a static control. (n =
3) C) Quantification of permeability coefficients for vessels lacking smooth muscle cell
incorporation. (n = 3) D) A representative image of smooth muscle cell orientation along
the endothelialized vessel. E) Relative gene expression of GFAP, HIF1alpha, and VEGF
of astrocytes isolated from regions adjacent to endothelial cells exposed to fully
developed (I), disturbed (II), impinged flow (III), and static conditions. (n = 3) * indicates
p < 0.05. N.S indicates no significant difference.
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In order to probe endothelial-mural crosstalk, permeability tests were repeated on
vessels with smooth muscle cells removed from the annulus. Given the effect of mural
cells on regulation of vascular tone107, lipid absorption108, and small GTPase signaling
within endothelial cells
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, these experiments interrogated whether smooth muscle cells

also influenced the response of the BBB to altered shear stress. Figure 8C indicates that the
absence of smooth muscle cells did not cause a significant effect in the permeability of the
endothelium in the disturbed and fully developed regions. Additional imaging experiments
were conducted to determine if the spatial organization of the smooth muscle cells varied
along the vessel (Fig. 8D). Quantification of the distance between smooth muscle cell
nuclei and the endothelial lumen indicated no significant difference between disturbed and
fully developed regions.
Astrocytes in regions adjacent to the three flow regimes (I: fully developed, II:
disturbed, and III: impinged) were isolated and lysed following application of flow to
determine whether glial cells mediated barrier disruption by undergoing activation or
increasing gene expression of paracrine factors known to cause barrier breakdown.
Although gene expression does not elucidate the underlying mechanisms regulating the
response of astrocytes to their environmental factors, this assay provides insight into
whether the flow regime affected the astrocyte cell response. Message level quantification
indicated no significant difference in the production of GFAP, which is indicative of glial
activation, or in the production of paracrine factors VEGF and HIF1α, which are known to
modulate vascular integrity and function. These results verified that astrocytes surrounding
the endothelium exposed to different flow regimes did not affect barrier integrity by
altering their gene expression.
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4.2. Impact Of Disturbed Pulsatile Flow On The Integrity Of The BBB
4.2.1. Pulsatile flow generation within the 3D bifurcation model. The
perfusion system portrayed in (Fig. 9 A-C) was designed to generate pulsatile, separated
flow waveforms inside a 3D vessel model by superposing oscillations on the constant
mean ﬂow generated by the peristaltic pump. A flow sensor was placed directly
upstream of the channel to measure flow rates (Fig. 9A). The linear actuator was
programmed to recreate the physiological flow waveform depicted in Figure 9D,
exhibiting four inflection points: (1) peak systolic pressure (2) reflected peak; (3)
dicrotic notch, and the (4) following peak [150]. This waveform was applied at a
frequency of 1-Hz to be appropriate for a human cardiac cycle.
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Figure 9. Pulsatile flow system design. A) Photograph of the perfusion system with the
peristaltic pump for steady flow generation and the Linmot oscillator for pulsatile
superposition. B) Schematic showing the flow circuit used to generate the flow
waveform. C) Plot of the physiological-like flow waveform generated with the perfusion
system showing the four characteristic points (1) peak systolic pressure; (2) reflected
peak, (3) dicrotic notch, and the (4) following peak. Dii) Comparison of the physiological
flow waveform and the flow measured in a human carotid artery CCA7, 110

4.2.2. Pulsatile flow characterization within the 3D vessel model using PIV
and CFD. In order to characterize the flow regimes within the 3D vessel model,
brightfield microscopy was used to measure the channel dimensions and orientation
using a previously described method 98. The geometry was imported into SolidWorks
(Fig. 8A) and then discretized with a polyhedral mesh (Fig. 10Bi,Bii) using a
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commercial computational fluid dynamics (CFD) code (Star CCM+). The CFD model
predicted separated flow regions at the near wall of the channel at the systolic peak and
the dicrotic and anacrotic notches (Fig. 10C-E), characterized by flow recirculation near
the wall. However, in the diastolic point, no recirculation eddies were present. Overall,
the computational model found a time-dependent velocity changing in direction and
magnitude during the course of the waveform.
Microparticle image velocimetry (PIV) was used to quantify the time-dependent
velocity profiles within the channel and validate the computational model. Pulsatile flow
was applied to the channel using the same waveform utilized in the CFD model, and the
velocity contour plots were calculated within the channel at the four characteristic time
points (Fig.9D). As Fig. 10C-F indicate, PIV demonstrated a similar region of separated
flow at the inlet of the channel as the computational model for the points 1,2 and 4.
However, both approaches confirmed there was no backflow measured at the wall. These
results demonstrate that the flow rate is the key parameter governing the flow patterns
within the channel. Therefore, the flow was causing recirculation eddies at high Reynolds
numbers (112, 133 and 306) in the dicrotic notch, the anacrotic notch and the systolic
peak respectively. On the other hand, Reynolds number below 100 (92 at the diastolic
point), was not high enough to cause substantial flow separation and recirculation within
the channel.

51

Figure 10. CFD velocity contour plots validated by microPIV along one cycle of the
waveform. A) A SolidWorks image of the channel geometry highlighting the hydrogel
positioning within the channel, B) Polyhedral mesh generated for the CFD model along
with the prism layers along the wall. C) Velocity contour plot at the systolic point
generated with the CFD and PIV, D) Velocity contour plot at the dicrotic notch
generated with the CFD and PIV. E) Velocity contour plot at the diastolic point
generated with the CFD and PIV and, F) Velocity contour plot at the anacrotic notch
generated with the CFD and PIV.

52

Comparing velocity profiles at three different axial positions provide a means to
more quantitatively assess the velocimetry validation of the CFD model. The axial
positions include x = 0.2 mm, 0.6 mm, and 1 mm from the inlet of the cell-seeded channel.
The plots in Fig. 9 confirm that at a distance of x = 1 mm from the inlet, the flow remained
disturbed for the systolic point and the dicrotic and anacrotic notches, evidenced by the
lack of a parabolic velocity profile and the negative velocity along the near wall. At the
disastolic point, the flow was not fully developed, but the boundary layer on the near wall
was not as substantially affected. However, for the diastolic point, while the velocity plot
exhibited an asymmetric profile and the flow was not fully developed yet, there was no
recirculation at the near wall of the channel, evidenced by the positive velocity values. The
radial velocity plots in the flow separation region (Fig.11 A,B,D)) indicated the flow
separation caused by the bifurcation in the peak systolic, the diacrotic notch and the
anacrotic notch.
For most data points, the computational values fall within one standard deviation of
the experimental measurement. While the peak systolic was characterized by minor
discrepancies between the experimental and computational results, the maximum velocity
and the asymmetry of the profile from both approaches were consistent. Conversely, the
velocity comparisons in the diastolic and the dicrotic and anacrotic notches reveal close
agreement between the predicted velocity distributions and those measured by PIV with
minimal variations between the 5 PIV measurements. Overall, these results
quantitatively validate the time-dependent velocity profiles predicted by the
computational model.
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Figure 11. Temporal-spatial matrix of velocity profiles in the bifurcation model., Ai)
Velocity profile at the systolic point along the channel radius at x= 0.2 mm Aii) x=
0.6mm, Aiii) and, x= 1mm., Bi) Velocity profile at the dicrotic notch along the channel
radius at x= 0.2 mm Bii) x= 0.6mm, Biii) and, x= 1mm. Ci) Velocity profile at the
diastolic point along the channel radius at x= 0.2 mm Cii) x= 0.6mm and, Ciii) x= 1mm.,
Di) Velocity profile at the anacrotic notch along the channel radius at x= 0.2 mm Dii) x=
0.6mm, and Diii) x= 1mm.Error bars indicate the standard deviation between 5 different
measurements.
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4.2.3. Measurement and validation of wall shear stress profiles along the near wall.

In addition to the velocity profiles, the computational fluid dynamic model (CFD)
predicted periodic changes in the instantaneous wall shear stress at different time points
of the cycle in the bifurcation model. Furthermore, these periodic changes resulted in
varying stagnation points along the channel wall which varied from 0.543 mm for the
systolic point (Fig. 12A) to 0.38 mm for the dicrotic and anacrotic notches (Fig. 12B, C).
As evidenced by the positive wall shear stress profile in Figure 12.D, no reattachment
point was observed in the diastolic flow due to the absence of recirculation at that time
point of the waveform. The PIV validated the wall shear stress profiles along
approximately a 1.2-mm-length of the channel adjacent to the bifurcation on the near wall
for the four different time points of the flow waveform. The plots showed close
agreement between the CFD-predicted wall shear stress profiles and those measured by
PIV, and verified that the systolic, dicrotic and anacrotic notches exhibited recirculation
regions at the near wall of the channel. In addition, the spatial and temporal
characteristics of the wall shear stress distributions were consistent with the measured
velocity profiles.
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Figure 12. Wall shear stress profiles along the near wall of the bifurcation model A-D)
comparison plots between the experimental and measured wall shear stress (WSS) profiles
along a 1.2-mm length of the near wall of the disturbed region for the four different time
points systolic point, the dicrotic notch, the diastolic point and ,the anacrotic notch in the
curve . Error bars indicate the standard deviation of 5 measurements for a duration of 5
seconds.

4.2.3. The impact of pulsatile flow on endothelial cells tight junctions and
barrier permeability. Having demonstrated the ability to apply pulsatile flow in the
cerebral bifurcation model, channels were perfused with pulsatile flow for 18h to assess
the effect of disturbed flow on the integrity of the blood-brain barrier and endothelial
cells tight junctions. Confocal images of the vessel revealed that ZO-1 was not fully
localized to cell-cell junctions (Fig. 13D-E), in the disturbed region with an increased
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stress fiber formation within the cells (Figure 13F). In contrast, endothelial cells exposed
to fully developed flow exhibited ZO-1 localization to the cell-cell junctions (Fig. 13AC) and appeared to be aligned to the flow direction. Alignment quantification was
verified by the Fast Fourier Transform (FFT) analysis. Results demonstrated that the cells
in the fully developed region were significantly more aligned in the direction of flow than
cells in the disturbed region (Fig. 13G-H). To determine whether the morphological
changes affected barrier integrity,.permeability tests were performed. Three vessels were
perfused with Dextran after 18 h of pulsatile flow perfusion. The permeability coefficient
measured at the fully developed region was significantly lower than the one measured at
the near wall where the flow separates (Figure 31.I). These results do not contradict our
previous study on the impact of steady disturbed flow on the BBB integrity inside a 3D
cerebral vasculature model. However, a transcriptional analysis is further needed to better
understand the mechanism by which endothelial cells respond to the different natures of
blood flow.
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Figure 13. Impact of pulsatile flow on the BBB integrity: A) Composite images of Zo1
staining(red), DAPI (blue) and phalloidin (green) for channels exposed to fully developed
flow, B) Zo1 channel isolated for channels exposed to fully developed flow, C) actin
channel isolated, D) Composite images of Zo1 staining(red), DAPI (blue) and phalloidin
(green) for channels exposed to disturbed flow, E) Zo1 channel isolated for channels
exposed to disturbed flow ,F) actin channel isolated, G) FFT pixels , H) width at half
height of the distributions for the fully developed and disturbed flow regions and I)
Permeability coefficient quantification for the fully developed and disturbed regions.
Arrows indicate the direction of flow. Scale bar: 50 um. * p < 0.05.

4.3. RNA Sequencing
4.3.1 General approach. Given the 944-m diameter of the vessel and a cell
density measured to be 182,430 cells/cm2 +/- 30,230 cell/cm2 on the near side of the
vessel, these studies suggest that 10,000-12,000 cells are exposed to separated flow in
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each experiment. To verify that this number is sufficient to conduct gene expression
analysis, mRNA was extracted from approximately 2-mm long regions of two separate
vessels exposed to disturbed,impinged flow, in addition to regions exposed to fully
developed flow. With the exception of the static condition, the three flow conditions were
derived from the same channels. These isolates exhibited sufficient quality for RNAsequencing (RIN > 6.0). To analyze the sequencing data, the raw file (Fastq files) were
imported in the FASTQC software to check the read quality. All bad reads (not satisfying
the Q30 threshhold) were trimmed using the trimmomatic Software. The reads were then
aligned to the genome using the STAR software. Finally, HTseq was utilized to assign
the aligned reads to genes.
4.3.1. Results.
4.3.1.1. Steady flow results.
4.3.1.1.1.

Principal component analysis. Differential gene analysis between

regions of the vessel exposed to disturbed, fully developed, impinged flow was
completed in addition to static conditions as control. To gain a better understanding of the
difference in gene expression between these groups, principal component analysis was
conducted using the results of RNA sequencing. Results (Figure 14.A) shows that the
data clustered in a shear dependent matter for the four different conditions. The static
condition is clustered in a region separate from the cells exposed to flow. This analysis is
repeated in Figure 14.B focusing on only fully developed and disturbed conditions, again
showing the clustering of these two groups. The principal component (PC1) shown in the
fully developed – disturbed comparison accounts for 80% of the variation in the data, as
plotted in Figure 14.C.
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A

Figure 14. Principal component analysis of the flow conditions. A) plots the data along
two components that show separation between the flow groups and static condition, as
well as differences between the flow regimes. B) plots focusing on fully developed and
disturbed conditions along two components. C) Percent variation plot for the analysis of
fully developed and disturbed conditions.
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4.3.1.1.2.

Differential gene expression analysis. The bioinformatics analysis

found differences in gene expression between the disturbed and fully developed regions
with 645 downregulated and 1040 upregulated genes respectively in the disturbed
compared to the fully developed region. The heatmap plot (Fig.15A) shows the 20 most
variable genes between the two different regions. Among these genes, the matrix
metalloproteinases MMP1, MMP3, MMP12 as well as lumican; a member of the small
leucine-rich proteoglycans (SLRPs) were shown to be significantly downregulated in the
disturbed region as validated by qrt-PCR (Fig 15.B). Lumican, which has been implicated
in ECM organization and collagen fibrillogensesis

111-113

, had a 10-fold increase in

expression in the fully developed region compared to the disturbed region. Furthermore,
lumican expression has been shown to regulate the activation of RhoA through multiple
interactions with Rho-GEFs, Rho-GAPs and their effectors in lung cancer
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. Therefore,

these initial studies not only demonstrate the validity of this approach, but also underscore
the potential of this model to investigate the effects of disturbed flow on the endothelial
cells within the BBB. The heatmap plot (Fig.15A) confirms the differentially expressed
genes and shows the 50 most variable genes between the two different regions.
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Figure 15. Differential gene expression analysis: A)Heatmap plot showing the difference
in expression of genes in the fully developed and disturbed regions using RNA
sequencing. B) Message level analysis of five most differentially expressed genes
identified usingqrt-PCR for vessels exposed to steady flow.

4.4. Impact of Lumican Knockdown On The Integrity Of The Barrier In The
Endothelium Exposed To Steady Flow
Experiments were conducted to determine whether knocking down lumican in
cells exposed to fully developed flow would also cause barrier breakdown, to establish
lumican as an important component of barrier formation and maintenance.
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4.4.1. Impact of disturbed flow on lumican localization. To further validate
the RNA sequencing results, immunofluorescence was utilized to qualitatively compare
the levels of lumican protein expressed by endothelial cells in the disturbed and fully
developed regions. Figure 16 shows that the lumican expression in the fully developed
region is spread more diffusely throughout the cell, while cells exposed to disturbed flow
exhibited substantially more perinuclear staining. These images also show the difference
in ZO-1 staining between fully developed and disturbed regions, supporting previous
results.

Figure 16. Impact of flow on Lumican expression. A) Immunofluorescence of
endothelial cells in fully developed and disturbed regions. DAPI (blue), anti-ZO-1 (red),
and anti-lumican (green) are shown. The right-side panels remove the DAPI stain to show
the difference in perinuclear staining between conditions. Scale 25um, B) Quantification
of lumican expression in flat gels exposed to fully developed and disturbed flow
conditions using western blot.
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To further determine whether the protein expression of lumican mirrors the
transcriptional changes, lumican expression by endothelial monolayers exposed to fully
developed and disturbed shear stress profiles using a rheometer was quantified using
western blot. Results showed that lumican expression in gels exposed to disturbed shear
stress profiles is significantly lower than those of fully developed flow further validating
that disturbed flow alters the expression of lumican.
4.4.2. Impact of lumican knockdown on the barrier integrity.
4.4.2.1. Lumican knockdown verification. Due to the length of time between
when the channel is seeded with endothelial cells and the permeability of the vessel is
measured (5 days), the siRNA knockdown efficiency was evaluated at day 5 posttransfection. The knockdown efficiency was verified using western blotting with antilumican primary antibodies and HRP-conjugated secondary antibodies. Western blotting
validated the effect of gene editing on Lumican expression. Figure 17 shows that the
siRNA is approximately 44% efficient in knocking down lumican expression in the
endothelial cells, as measured by Western blot.
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Figure 17. Lumican knockdown studies. A) Validation of knockdown efficiency at day 5
post-transfection.

4.4.2.2. Impact of lumican knockdown on the barrier integrity under steady and
pulsatile flow conditions. Two conditions (knockdown and control) were evaluated to
determine whether depletion in Lumican impacted he barrier integrity for the steady and
pulsatile flow conditions. Immunofluoresence staining showed that the knockdown
affected the expression of ZO-1 (red) (green) which was markedly different from the
control cells. Vessels treated with scrambled guide sequences were not affected by
transfection, ZO-1 is observed at the cell-cell junctions with minimal perinuclear
localization. Figure 18.A illustrates the difference in ZO-1 localization to cell-cell
junctions in scrambled and knockdown conditions. The knockdown condition resembles
the cells exposed to the disturbed flow regimes, indicating substantial barrier breakdown.
The immunofluorescence studies were validated by dextran permeability quantification.
Knocking down lumican expression drastically altered the barrier response to fully
developed flow under steady and pulsatile flow conditions. Figure 18.B finds that using
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siRNA to knockdown lumican expression significantly increases the permeability to 4kDa FITC-labeled dextran. While the permeability of knockdown vessels is not
statistically different from vessels exposed to the disturbed flow regimes in the steady
flow condition (Fig 18.C), the permeability coefficients for the knockdown and disturbed
flow region in the pulsatile flow condition were statistically different (Fig 18.D).
Altogether, these results indicate that lumican plays an important role in regulating
barrier integrity under steady and pulsatile flow.

Figure 18. Impact of lumican knockdown on barrier integrity for steady and pulsatile
flows A) Immunofluorescence of scrambled and knockdown conditions in the fully
developed flow regime. B) Permeability coefficients calculated from 4-kDa FITC dextran
for steady flow and pulsatile flow conditions, C) Comparison of permeability
coefficients between scrambled control and fully developed flow conditions and
knockdown and disturbed conditions for the steady flow, and D) Comparison of
permeability coefficients between scrambled control and fully developed flow conditions
and knockdown and disturbed conditions for the pulsatile flow.
66
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mechanotransduction. Previous studies have found that lumican expression alters
Rho/ROCK activity, therefore cells treated with knockdown and scrambled siRNA were
seeded into channels and exposed to flow prior to measurements of barrier integrity.
Studies were conducted to determine the effect of shear stress on RhoA activation within
the 3D BBB model. ELISA assays provided further insight into the effect of flow on the
activation of small GTPases.

Figure 19. Impact of lumican knockdown on RhoA activation.

Figure 19 shows that there is no statistical difference between the knockdown and
scrambled control in the level of RhoA activity, as measured by ELISA assay. Although
lumican has a substantial impact on barrier breakdown, these assays indicate that lumican
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does not contribute to changes in RhoA activation suggesting that other specific
components of the mechanosensing complex are associated with the blood-brain barrier
response to fluid shear stress in the cerebral artery.
4.5. Lumican Mechanics
In order to determine whether lumican alters the mechanics of the surrounding
ECM, rheological characterization was conducted to determine whether the presence of
the proteoglycan would affect polymerization and viscoelastic properties of a collagen
hydrogel.
4.5.1.

Turbidity assays and rheology results. The addition of lumican was

shown to increase the stiffness of the gel compared to collagen without lumican (Fig.
20A). However, lumican increases the time required for the gel to polymerize in a dose
dependent manner, indicating that lumican alters crosslinking process. Fibrillogenesis
assays confirmed the effect of the proteoglycan. Initially, the impact of recombinant
lumican on collagen fibril formation was measured for three different lumican
concentrations (0.01 mg/mL, 0.05mg/mL, and 0.075 mg/mL) (Fig 20.D). Lumican was
shown to have an impact on collagen fibrillogenesis compared to the control sample
lacking the lumican. Results showed that the addition of lumican increased the time taken
before initial fibril formation happened compared to control conditons (collagen only).
Therefore, lumican slows down fibrillogenesis with a lower fibril formation plateau. At
the end of fibrillogenesis, lumican resulted in overall reduced turbidity indicating a lower
fibril diameter compared to the control condition in addition to enhancing collagen fibril
stability. These findings suggest that lumican stabilizes the fibril and limits fibril growth
which is consistent with previous studies100. Therefore, this would reduce rearrangement
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of collagen molecules within collagen fibrils in vivo, and reduce heterogeneity of fibril
diameter 100.

Figure 20. Impact of lumican proteoglycan on collagen fibrillogenesis and mechanical
properties. A) Storage moduus of collagen, and collagen-lumican mixtures, B) Loss
modulus of collagen, and collagen-lumican mixtures, C) Impact of lumican on collagen
polymerization and , D) Absorbance curve for collagen and collagen-lumican mixtures.
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Chapter V
Discussion

5.1. Disturbed Flow Disrupts The Blood-Brain Barrier In A 3D Bifurcation Model

These results reinforce the growing evidence that fluid shear stress modulates the
integrity of the BBB. Whereas a previous study from one of our groups demonstrated the
protective effects of low levels of shear on the BBB15 , here, our findings indicate that shear
stress altered by disturbed flow has the opposite effect. Endothelial cells within the region
of separated flow exhibit altered morphology, increased permeability, and higher
proliferation rates compared to cells in the fully developed flow region downstream of the
bifurcation. Although previous studies have identified similar consequences of disturbed
flow in other parts of the body54, the current findings show that vasculature in the brain is
also impacted by the altered shear stress exerted by separated flow. Because the barrier
function of brain vasculature is more vital than vasculature in other regions of the body due
to the inflammation caused by the leakage of plasma components into the brain
parenchyma, these results underscore the impact of disturbed blood flow in the brain.
Additionally, given that recent studies115, 116 have found transcellular breakdown precedes
the paracellular transport measured here, the effect of disturbed flow on the barrier may be
even more pronounced than our experiments indicate.
The results also demonstrate that the cerebral bifurcation model provides a robust
platform to study the response of brain vasculature to complex fluid mechanics. Unlike
previous in vitro models designed to exert disturbed flow on endothelial cells, the current
model preserves the three-dimensionality of the in vivo environment and incorporates both
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mural and glial cells in the surrounding hydrogel. Although our results suggest that smooth
muscle cells and astrocytes do not modulate the endothelial response to disturbed flow,
these findings do not contradict previous findings on the importance of endothelial-mural
and endothelial-glial crosstalk. Rather, the results indicate that the endothelium modulates
tight junction integrity in response to fluid shear stress independent of other cell types,
which is consistent with a previous finding that cerebral endothelial cells exposed to shear
stress form tight junctions in the absence of astrocytes15. Although the model mimics
certain aspects of in vivo vasculature that have yet to be incorporated in vitro, it does not
fully recreate the in vivo microenvironment and focuses on a rather short (24-hour) time
frame. There are differences in both the ECM content (brain tissue contains minimal
fibrillar collagen type I) and a lack of cell types including microglia, pericytes, and
macrophages that could affect the specific range and magnitude of shear stress that causes
barrier breakdown in vivo. Furthermore, the current microfluidic device exhibits a fixed
bifurcation geometry, since the inlet is offset by 45 degrees, and thus cannot mimic the
variability present in cerebral bifurcations. Therefore, future work is required to determine
whether barrier function is generally reduced adjacent to bifurcations in the brain or
additional factors known to exacerbate the effects of disturbed flow in systemic
vasculature24 also exert the same effect on the blood-brain barrier.
However, despite these differences with in vivo vasculature, a particular advantage of this
in vitro model is the use of CFD and PIV to predict and validate the complex flow fields
generated in the device. These methods are vital to assuring consistency between the
varying channels, since the fabrication of the cell-seeded hydrogels results in small
differences in geometries that affect the flow field.
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5.2. Impact Of Pulsatile Flow On The BBB
The perfusion system developed here represents a robust, reproducible platform to
interrogate the response of cerebral endothelial cells to complex, time-dependent flow
fields within 3D protein-based hydrogel microenvironments. Computational fluid
dynamics predict a spatial and temporal varying flow field within the channel during
application of pulsatile flow, and microparticle image velocimetry validates the model by
measuring flow separation at several points within the flow waveform. Both the velocity
and wall shear stress profiles demonstrate that disturbed flow patterns exhibit periodic
changes in the length of recirculating flow varying from x = 0-mm to approximately
0.55-mm along the near wall of the channel. Endothelial cells within the region of
separated flow exhibited altered morphology and tight junctions as well as increased
permeability compared to cells in the fully developed flow region downstream of the
bifurcation. Overall, these results establish this perfusion system as a means to apply
time-dependent, reproducible flow fields to complex vascular geometries, in addition to
providing preliminary insight into the effect of pulsatile, disturbed flow on the integrity
of the blood-brain barrier,
The perfusion system has sufficient flexibility to mimic a variety of flow
waveforms. The waveform used in this study mimics aspects of cerebral blood flow
including the systolic and diastolic phases in addition to the inflection points. However,
the effect of channel wall compliance can also be assessed in future studies. Intracranial
pulsations may play an active role in intracranial fluid dynamics and brain compliance117.
3D vessel models combined with the pulsatile perfusion system can be used to investigate
the impact of wall compliance on the flow velocity and shear stress profiles. Furthermore,
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future studies can also use non-Newtonian fluids to better understand blood flow in
complex arterial topologies.

Moreover, the perfusion system can be used to learn more about the
mechanobiological response of endothelial cells to complex flow regimes. The results
presented here indicate that pulsatile disturbed flow attenuates barrier function compared
to fully developed pulsatile flow.

5.3. Establishing A Mechanistic Link Between Disturbed Flow And Aneurysm
Formation
RNA sequencing found differences in gene expression between the disturbed and
fully developed regions with 645 downregulated and 1040 upregulated genes respectively
in the disturbed compared to the fully developed region. Additionally, lumican which has
been implicated in ECM organization and collagen fibrillogensesis111-113, was shown to be
significantly upregulated in the fully developed region. Furthermore, the experiments
conducted demonstrated that lumican is involved in collagen fibrillogenesis and mediating
barrier integrity. The downregulation of the protein is associated with barrier breakdown.
However, knocking down lumican has no significant effect on the activity of RhoA.
Therefore, the breakdown of the barrier and the reduced expression of lumican are not
correlated to increased RhoA activation, suggesting that other mechanisms are involved.
5.4. Future Work
These results are the first to identify lumican as a potential mediator of cerebral
aneurysm formation and are therefore a starting point for translational studies that
interrogate the proteoglycan as both a therapeutic target and diagnostic candidate. Previous
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work in abdominal aneurysms have investigated using lumican levels to diagnose patients
at risk for developing such aneurysms. Our results suggest that future studies can
interrogate whether lumican is also a marker for cerebral aneurysms. Moreover, these
results indicate that lumican is an important mediator of extracellular matrix mechanics.
This finding can form the basis of future biophysics studies to determine how
proteoglycans modify the properties of viscoelastic substrates, and use this knowledge to
advance tissue engineering and regenerative medicine applications in order to increase the
clinical impact of this work.
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Appendix A
Characterization Of The Channel Geometry

Figure A1. Bright field image of the channel geometry
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Appendix B
Vessel Fabrication Process

Figure B1. Vessel fabrication process
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Appendix C
Flow Controller Setup.

Figure C1. Electrical connections and feedback, along with the flow circuit used to
perfuse the devices.
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Appendix D
Microparticle Image Velocimetry

Figure D1. Microparticle image velocimetry experiment. The tracer solution was
prepared from Nile Red-labeled Polyethylene Microspheres (Peak excitation: 640nm;
mean diameter 1.95um; Spherotech Inc.) The beads were illuminated and visualized with
a dual pulse laser. The velocity was measured by tracking the beads movement
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Appendix E
Immunofluorescence Using Claudin-5 And Occluden

Figure E1. Confirmation of tight junction formation and disruption. A-C) Composite
images of occludin (red), DAPI (blue), and phalloidin (green) (i) and with occludin
isolated (ii) of the endothelial cells along the near side wall in static conditions (A) and in
perfused channels at the fully developed (B) and stagnation point of the disturbed region
(C). D-F) Composite images of occludin (red), DAPI (blue), and phalloidin (green) (i)
and with occludin isolated (ii) of the endothelial cells along the near side wall in static
conditions (D) and in perfused channels at the fully developed (E) and stagnation point of
the disturbed region (F). Scale for all frames: 25 m.
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Appendix F
Verification Of Dextran Transport Across The Cell-Seeded Vessel.

Figure F1. A) Dextran transport across the axial direction, B)Dextran transport across
the radial direction, C) Relative intensity along the axial distance and, D) Relative
intensity along the radial distance.

91

Appendix G
Final 3D Printed Components

Figure G1. Device construction and assembly. A) CAD renderings (Solidworks) of the
syringe components. B) Photographs of the printed components. C) CAD rendering of the
linear actuator-syringe assembly.
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Appendix H
Impact Of Disturbed Flow On Lumican Protein Expression

Figure H1. Rheometer setup used for the study of the impact of disturbed flow on protein
expression
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